Showing results (1151-1160 of 2,877) with videos related to

Sort By:
Pageof 288
Molecular Diversity|June 4, 2026
Synthesis and fungicidal activity of novel 1,1-diaryl-2-azolylethanols with a pyridine moietyMinghui Chen, Fahong Yin, Sai Hong, et al.
Molecular Diversity|June 4, 2026
Discovery, synthesis, and anti-cancer activity of N-CF3-benzimidazolesQigang Sun, Jia-Yi Li, Qingjiang Li, et al.
Molecular Diversity|October 19, 2021
PANI-Fe3O4@ZnO nanocomposite as magnetically recoverable organometallic nanocatalyst promoted synthesis of new Azo chromene dyes and evaluation of their antioxidant and antimicrobial activitiesShahrzad Abdolmohammadi, Zinatossadat Hossaini, Mohammad Reza Poor Heravi
Molecular Diversity|March 30, 2022
Sulfonated magnetic sugarcane bagasse as an efficient natural polymer-based catalyst for the synthesis of nitrogen-containing heterocyclic rings in waterFahimeh Kazeminava, Ziba Tavakoli
Molecular Diversity|June 6, 2023
Structural insights and cytotoxicity evaluation of benz[e]indole pyrazolyl-substituted amidesAbdul Qaiyum Ramle, Nadia Nabihah Mohd Yusof Chan, Min Phin Ng, et al.
Molecular Diversity|December 8, 2023
Synthesis of pyrano-pyrimidines: recent advances in catalysis by magnetically recoverable nanocatalystsAli Noory Fajer, Hussein Ali Al-Bahrani, Abud Amir Hussan Kadhum, et al.
Molecular Diversity|May 19, 2026
Triazole-based inhibitors for breast cancer: biological activity, SAR and synthetic strategiesMohit Sharma, Ankur Gandhi, Kalicharan Sharma
Molecular Diversity|May 23, 2026
Exploring the renoprotective potential of Beta vulgaris in diabetic nephropathy: an integrated network pharmacology, molecular docking and dynamics simulation studyAbhishek Sehrawat, Yogesh Singh, Khushi Gupta, et al.
Molecular Diversity|May 21, 2026
Recent advancements in microtubule targeting agents for breast cancer: design strategies and pharmacological insightsParamjeet Kaur, Rajiv Sharma
Molecular Diversity|May 28, 2026
Design, synthesis, and biological evaluation of glycyrrhetinic acid-cinnamamide derivatives as HMGB1/TLR4 pathway inhibitors for sepsis-induced liver injuryJiao Wang, Tian Guo, Zhe Zheng, et al.
Pageof 288